ClinicalTrials.Veeva

Menu
C

Cooper University Health Care | Internal Medicine Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Fentanyl Citrate
Budigalimab
Lidocaine
ABBV-382
Bevacizumab
Ketamine Hydrochloride

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 8 total trials

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Enrolling
Human Immuno-deficiency Virus (HIV) Disease
Drug: Budigalimab
Drug: ABBV-382

Trial sponsors

Cooper University Health Care logo
AbbVie logo
Boston Medical Center (BMC) logo
I
M
University of North Carolina (UNC) logo
J

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems